Inventor · disambiguated record
John Stuart Crawford
Also filed as: CRAWFORD JOHN S · CRAWFORD JOHN STUART
8 granted patents·16 pending applications·74 citations·filing 1981–2023
85Inventor score
Files withOSTERTAG ERIC M8TRANSPOSAGEN BIOPHARMACEUTICALS INC7HERA TESTING LABORATORIES INC6POSEIDA THERAPEUTICS INC2HOSPITAL FOR SICK CHILDREN1
Top patents by PatentIndex Score
24 records- 0190US8558055B2Genetically modified rat comprising a cytokine gene disruption and exhibiting a greater susceptibility to a cytokine-mediated autoimmune and/or inflammatory diseaseOSTERTAG ERIC M·Filed 2010·Granted Oct 15, 2013·16 cites·47 claims
- 0286US8722964B2Genetically engineered or transgenic rats exhibiting a cancer phenotype due to a disruption of germline tumor suppressor genesOSTERTAG ERIC M·Filed 2010·Granted May 13, 2014·11 cites·34 claims
- 0385US9314005B2Genetically modified rat models for severe combined immunodeficiency (SCID)OSTERTAG ERIC M·Filed 2010·Granted Apr 19, 2016·7 cites·5 claims
- 0484US11089765B2Genetically modified rat models for severe combined immunodeficiency (SCID)HERA TESTING LABORATORIES INC·Filed 2017·Granted Aug 17, 2021·2 cites·12 claims
- 0584US2024156069A1Genetically modified rat models for severe combined immunodeficiency (scid)HERA TESTING LABORATORIES INC·Filed 2023·Application pending·0 cites
- 0677US11849709B2Genetically modified rat models for severe combined immunodeficiency (SCID)HERA TESTING LABORATORIES INC·Filed 2021·Granted Dec 26, 2023·0 cites·21 claims
- 0777US10131634B2Method of treating painPOSEIDA THERAPEUTICS INC·Filed 2014·Granted Nov 20, 2018·1 cites·2 claims
- 0875US12274247B2Genetically modified rat models for severe combined immunodeficiency (SCID)HERA TESTING LABORATORIES INC·Filed 2021·Granted Apr 15, 2025·0 cites·17 claims
- 0960US2016302397A1Genetically modified rat models for severe combined immunodeficiency (scid)TRANSPOSAGEN BIOPHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 1056US2019135759A1Method of treating painPOSEIDA THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 1156US2015052624A1Genetically modified rat models for painTRANSPOSAGEN BIOPHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1255US2015052623A1Genetically modified rat models for pharmacokineticsTRANSPOSAGEN BIOPHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1355US2016174533A1Genetically modified rat models for drug metabolismTRANSPOSAGEN BIOPHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 1453US2016174534A1Genetically modified rat models for pharmacokineticsTRANSPOSAGEN BIOPHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 1553US2016174532A1Genetically modified rat models for painTRANSPOSAGEN BIOPHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 1650US2011145936A1Genetically Modified Rat Models for PharmacokineticsOSTERTAG ERIC M·Filed 2010·Application pending·0 cites
- 1749US2014041063A1Genetically Modified Rat Models for Obesity and DiabetesTRANSPOSAGEN BIOPHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 1848US4380239AIntubation of lacrimal ductsHOSPITAL FOR SICK CHILDREN·Filed 1981·Granted Apr 19, 1983·37 cites·8 claims
- 1948US2012151609A1Genetically Modified Rat Models for PainOSTERTAG ERIC M·Filed 2010·Application pending·0 cites
- 2048US2014201858A1Methods for site-specific genetic modification in stem cells using xanthomonas tal nucleases (xtn) for the creation of model organismsOSTERTAG ERIC M·Filed 2012·Application pending·0 cites
- 2148US2011035816A1Genetically Modified Rat Models for Drug MetabolismOSTERTAG ERIC M·Filed 2010·Application pending·0 cites
- 2242US2017112108A1Genetically modified non-human mammals having modified liver cells and/or tissue and methods of making sameHERA TESTING LABORATORIES INC·Filed 2016·Application pending·0 cites
- 2337US2021092942A1Novel immunodeficient rat for modeling human cancerHERA TESTING LABORATORIES INC·Filed 2018·Application pending·0 cites
- 2435US2012148604A1Trp inhibitors and uses thereofOSTERTAG ERIC M·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →